RxDoctor Payments Data

Sarah Nelson

Family · Eastvale, CANPI 1518414515

Payments from drug & device makers

$3,528in general payments, 2019–2025

Across 168 payments — averaging $21.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$478
  • AbbVie$435
  • Novo Nordisk$362
  • Lilly USA, LLC$265
  • Amgen$193
  • Biohaven Pharmaceutical Holding Company Ltd.$184
  • plus $2K from 27 others

What the payments were for

  • Food & beverage$3,528100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,528 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide27$25,192
TrulicityDulaglutide12$20,516
MounjaroTirzepatide17$19,980
ElmironPentosan Polysulfate Sodium13$13,096
RelistorMethylnaltrexone Bromide11$12,414
EliquisApixaban13$9,562
Repatha SureclickEvolocumab11$6,069
JanumetSitagliptin Phos/Metformin Hcl11$6,063
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$5,218
Atorvastatin Calcium211$1,762
Gabapentin141$1,746
SynthroidLevothyroxine Sodium15$1,439
Varenicline Tartrate17$1,365
Levothyroxine Sodium118$1,230
Amlodipine Besylate165$1,019

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$265$40,49629 claims
Novo NordiskOzempic$362$25,19227 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$70$12,41411 claims
PfizerEliquis$149$9,56213 claims
MerckJanumet$16$6,06311 claims
AbbVieSynthroid$435$1,43915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.

Other family in Eastvale

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →